Inflammaging: The Hidden Driver of Structural Aging

In 2000, immunologist Claudio Franceschi coined the term 'inflammaging' to describe a phenomenon that had been accumulating in the scientific literature for decades: the observation that aging is accompanied by a chronic, low-grade, systemic inflammatory state — even in the absence of acute infection or injury.

This is not the inflammation you feel when you cut your finger. It's quieter, slower, and far more damaging over time. And in the skin, it is one of the primary drivers of structural aging.

How inflammaging damages skin. Chronic low-grade inflammation activates matrix metalloproteinases (MMPs) — enzymes that break down collagen and elastin in the extracellular matrix (ECM). It upregulates pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α, which further accelerate ECM degradation. It impairs fibroblast function, reducing the skin's capacity to synthesise new collagen. And it disrupts the skin barrier, increasing transepidermal water loss and sensitising the skin to environmental stressors.

The result is the structural collapse that characterises aged skin: loss of volume, deepening of lines and folds, reduced elasticity, and a compromised barrier that struggles to retain moisture and resist irritants.

What drives inflammaging in skin. UV radiation is the most significant exogenous driver — it activates NF-κB, the master regulator of inflammation, and triggers a cascade of pro-inflammatory signalling. Pollution, particularly particulate matter, activates the same pathway through oxidative stress. Glycation — the non-enzymatic reaction between glucose and proteins — produces advanced glycation end-products (AGEs) that cross-link collagen and trigger inflammatory responses. And the skin's own aging process — the accumulation of senescent cells that secrete pro-inflammatory factors — contributes to a self-reinforcing cycle.

STRESSDEFENSE™ and the anti-inflammaging approach. STRESSDEFENSE™ was formulated specifically to interrupt this cycle. Neutrazen™ (palmitoyl tripeptide-8) reduces neurogenic inflammation by inhibiting substance P-mediated vasodilation and oedema — addressing one of the key upstream triggers of the inflammaging cascade. Lipochroman™-6 is a potent lipophilic antioxidant that neutralises reactive oxygen species before they can activate NF-κB. Chronoboost™ supports circadian regulation of skin repair, ensuring the skin's anti-inflammatory mechanisms are active at the right time of day.

This is not a 'calming' serum in the conventional sense. It is a targeted intervention in the biological pathway that drives structural aging — formulated at concentrations that produce measurable results, not just a pleasant texture.